バイオディフェンス市場 - 2031 年の成長予測、統計および事実

  • Report Code : TIPRE00005377
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 136
Buy Now

バイオディフェンス市場は、2019 年の 41 億 824 万米ドルから、2027 年には 83 億 5,074 万米ドルに達すると予想されています。市場は、2020 年から 2027 年にかけて 9.4% の CAGR で成長すると推定されています。< /h3>

バイオディフェンスとは、生物学的脅威や感染症にさらされている、またはその可能性がある生物群のバイオセキュリティを回復するために取られる措置を指します。これは、生物学的脅威に対抗し、病気の蔓延を制限し、急増する医療を提供するために設計された、強力な疾病監視と迅速な措置を備えた効果的な公衆衛生システムです。市場の成長は、政府の有利な取り組みの存在、自然発生の発生数の増加、生物兵器や核兵器搭載ICBMの脅威の増大など、いくつかの重要な推進要因によるものと考えられています。ただし、発展途上国および後進国では政府による研究開発資金が少ないため、予測数年間のバイオディフェンス市場の成長が抑制されると予想されます。

有利な地域のバイオ防衛市場



市場洞察

有利な政府の取り組みの存在

< p>政府は毎年、バイオテロ攻撃に備えてワクチンの研究開発に多額の費用を費やしている。たとえば、2018 年に米国政府は、国家バイオディフェンス戦略および実施計画、国家安全保障戦略、国家防衛戦略、国家対テロ戦略、国家対大量破壊兵器戦略を発表しましたが、これらのすべてにバイオセキュリティとバイオディフェンスが含まれています。さらに、米国政府は世界保健安全保障戦略の準備を進めており、自然、偶発的、意図的な生物学的脅威の予防、検出、対応を含む世界保健安全保障アジェンダの2024年の枠組みの開発を支援している。

インフルエンザ ワクチンと健康安全保障の強化は、大統領令 13887、「国家安全保障と公衆衛生を促進するために米国におけるインフルエンザ ワクチンを近代化する」を支援する予算です。保健福祉サービス(HHS)全体で、インフルエンザワクチンの製造インフラとイノベーションのために、2020年の制定水準と比較して9,500万ドルの増額を提供する。改良されたワクチン、治療薬、診断法の高度な研究開発。国際的なパンデミックへの備え。そして全国的なワクチン接種率が向上しました。この予算はまた、バイオシールド プログラムと戦略的国家備蓄を通じた HHS の生物防衛と緊急事態への備えの調達にも資金を提供します。この予算には、CDC の世界的な健康安全保障活動を支援するための 1 億 7,500 万ドルが含まれており、2020 年に制定された水準と比較して 5,000 万ドル増加しています。

政府は現在および将来のこれらの活動に取り組んでいます。政策活動、既存のバイオセキュリティおよびバイオディフェンス政策を理解することにより、バイオディフェンス市場で事業を展開する製薬会社には、拡大し、あらゆるバイオテロリズムに備えるための大きな機会が与えられます。例えば、抗生物質の開発会社スペロ・セラピューティクス社は、炭疽菌、ペスト、鼻疽症などの生物学的脅威に対する薬剤の有効性を評価するため、経口カルバペネム系候補薬SPR994について生物医学先端研究開発局から1,570万ドルの連邦研究資金を受け取った。さらに、生物医学先端研究開発局には、5 年間で最大 2,850 万ドルの追加予算も含まれており、薬剤耐性菌によって引き起こされる複雑な尿路感染症におけるスペロ社の SPR994 の臨床開発も支援する予定です。世界中の政府の取り組みは、バイオディフェンス分野に携わる企業にチャンスの窓を開きます。

製品インサイト

製品別のバイオディフェンス市場、炭疽菌、天然痘、ボツリヌス症、放射線・核などに分類されます。 2019年、炭疽菌セグメントは世界のバイオディフェンス市場で最大の市場シェアを占めました。この部門は、主にバイオシールド法、生物医学先端研究開発局(BARDA)などのさまざまな取り組みを通じて、炭疽菌に対する適切なワクチンを開発および備蓄するための他国の政府による資金提供が増加しているため、予測期間中も優位性を維持すると予想されています。 )、および化学および化学共同プログラム事務局生物防御。

世界の生物防御市場、製品別 – 2018年& 2027年



戦略的洞察

製品の発売と承認戦略は、世界中で事業展開を拡大するために企業によって一般的に採用されており、高まる需要に応えます。この戦略は、製品ポートフォリオを拡大するために市場関係者によって最も一般的に採用されています。

バイオディフェンス市場で事業を展開している市場関係者は、顧客ベースを拡大するために拡大戦略を採用しています。これにより、プレーヤーはブランド名を世界的に維持することができます。たとえば、2017 年 1 月、Emergent BioSolutions Inc. は、ドイツの Building 55 で製造された BioThrax (炭疽菌ワクチン吸着型) を販売するためのドイツ連邦保健省の承認を取得しました。

世界のバイオディフェンス市場–製品別

  • 炭疽病
  • 天然痘
  • ボツリヌス症
  • 放射線/核
  • その他

バイオディフェンス市場 –地理別

  • 北アメリカ
    • 米国
    • カナダ
    • メキシコ
  • < li>ヨーロッパ
    • フランス
    • ドイツ
    • イタリア
    • イギリス
    • スペイン
    • 残りヨーロッパ
  • アジア太平洋
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア
    • その他のアジア太平洋地域
  • 中東およびその他の地域
  • アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 中東およびアフリカのその他の地域
  • 南アメリカ
    • ブラジル
    • アルゼンチン
    • 南アメリカのその他の地域
  • 会社概要

    • 北欧バイエルン州
    • Alnylam Pharmaceuticals, Inc.
    • SIGA Technologies
    • < li>Emergent BioSolutions Inc.
    • Cleveland Bio Labs
    • Dynavax Technologies
    • Elusys Therapeutics, Inc.
    • Soligenix
    • < li>アルティミューン
    • プルリステム療法
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    Frequently Asked Questions


    What is biodefense?

    Biodefense is referred to the measures taken to restore biosecurity of a group of organism that are, or may be, subject to biological threats or infectious diseases. It is an effective public health care system with strong disease surveillance and rapid actions designed to counter biological threats, to limit the spread of disease and provide surge medical care.

    What are the driving factors for the bioresorbable medical materials market across the globe?

    Driving factors such as presence of favorable government initiatives increase in the number of naturally occurring outbreaks, increasing threat of biological weapons and nuclear armed ICBM. Additionally, the future trend such as predictive analytics to reshape biodefense market is likely to increase the growth in the forecast period.

    What is the regional analysis in terms of bioresorbable medical materials?

    Global biodefense market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for biodefense. Biological threats occurring to humans, animals and environment are among the most serious issues faced by the US and its national community. As the biological threat continues to increase, the US is focused towards strengthening its capabilities and considering preparation for bio threats and bioterrorism as one of the critical aspects of national security. The federal government in the US coordinates programs, and sets up budgets so as to prevent, respond and take actions against biological disasters.

    The List of Companies - Biodefense Market

    1. Bavarian Nordic
    2. Alnylam Pharmaceuticals, Inc.
    3. SIGA Technologies
    4. Emergent BioSolutions Inc.
    5. Cleveland Bio Labs
    6. Dynavax Technologies
    7. Elusys Therapeutics, Inc.
    8. Soligenix
    9. Altimmune
    10. Pluristem Therapeutics

    The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

    1. Data Collection and Secondary Research:

    As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

    Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

    1. Primary Research:

    The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

    For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

    A typical research interview fulfils the following functions:

    • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
    • Validates and strengthens in-house secondary research findings
    • Develops the analysis team’s expertise and market understanding

    Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

    • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
    • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

    Below is the breakup of our primary respondents by company, designation, and region:

    Research Methodology

    Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

    1. Data Analysis:

    Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

    • Macro-Economic Factor Analysis:

    We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

    • Country Level Data:

    Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

    • Company Profile:

    The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

    • Developing Base Number:

    Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

    1. Data Triangulation and Final Review:

    The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

    We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

    We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Related Reports